Imexhs Ltd · ASX:IME
Imexhs — Investor Presentation (February 2024)
24 slides from Imexhs's investor presentation, Feb 29, 2024
Slide 1: FY23 Results
FY23 Results 29 February 2024
Slide 2: Agenda
Agenda FY23 Results 1. Overview 2. Results Highlights 3. Financials 4. Strategy & Outlook 2
Slide 3: Overview
imexHSs Overview
Slide 4: One Company with two businesses aimed at democratising access to medical imaging expertise
One Company with two businesses aimed at democratising access to medical imaging expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 4
Slide 5: Global footprint
Global footprint Software 18 countries; 485 sites 3,184 radiologists 28 distributors in 15 countries Radiology Colombia, Spain and Mexico 35 radiology centres 150+ in-house radiologists 5
Slide 6: FY23 Results Highlights
imexHs FY23 Results Highlights
Slide 7: Business Highlights
Business Highlights • The Company has demonstrated the scalability of the business across different geographies with an attractive product and disruptive business model and now is focused on generating positive earnings and cashflow. • Focus is on sales within Latin America and those product develop
Slide 8: FY23 Operational Highlights
FY23 Operational Highlights • Signed a new 5-year Software as a Service • Two new radiology services contracts signed (SaaS) contract with Grupo Avidanti – Zentria. with Famisanar, Colombia’s fifth largest The contract is priced in USD, has a TCV of insurance provider, with a combined ARR of A$2.1m
Slide 9: FY23 Financial Highlights
FY23 Financial Highlights Sales Revenue Annual Recurring Underlying Revenue (ARR) 2 EBITDA3 Up 15% yoy $19.7m Up 27% yoy $25.0m Up $0.5m yoy $0.4m Up 11% on a constant Up 1% on a constant vs ($0.1m) currency basis1 currency basis 2H Revenue Closing cash Debt Up 23% vs 1H FY23 $10.9m vs $1.9m at 31 $
Slide 10: FY23 Business Unit Results
FY23 Business Unit Results • Software primarily relates to sales of $M Software Radiology Corporate Total IMEXHS Enterprise and growing IMEXHS Cloud business ➢ Revenue up 19% yoy Revenue 7.6 12.1 - 19.7 ➢ ARR up 14% Underlying • Radiology includes RIMAB along with 3.0 (0.6) (2.0) 0.4 EBITDA other se
Slide 11: FY23 Financials
imex<«Hs FY23 Financials
Slide 12: Progress in ARR
Progress in ARR ARR as at 31 December 2023 • $25.0m, up 27% vs pcp; up 1% on a constant currency basis ➢ Radiology services - $14.5m, up 38% vs pcp ($10.5m at 31 Dec-22) and ➢ Software - $10.5m, up 14% vs pcp ($9.2m at 31 Dec-22). (1) Constant currency basis assumes that historical results at each y
Slide 13: Income Statement
Income Statement $'000 FY23 FY22 Var Var % • Revenue of $19.7m, up 15% yoy and 11% on a constant currency basis Revenue 19,669 17,117 2,552 15% • Underlying EBITDA of $0.4m up Other revenue 252 174 78 45% $0.5m versus pcp loss of $0.1m Total revenue 19,921 17,292 2,630 15% • Underlying EBITDA exclud
Slide 14: Balance Sheet
Balance Sheet $'000 Dec 23 Dec 22 • Closing cash balance of $2.4m as at 31 Cash 2,362 1,912 December 2023 and Net Assets of $16.0m Trade & other receivables 6,443 6,154 • Intangible assets of $8.6m include Goodwill of Inventories 112 97 $4.8m, Software of $2.7m, $0.9m of customer Current assets 8,91
Slide 15: Summary Cash Flow
Summary Cash Flow $'000 FY23 FY22 • Closing cash balance of $2.4m as at 31-Dec-23 vs pcp of $1.9m Net cash (used in)/from operating activities 2,610 (2,198) Net cash (used in)/from investing activities (2,133) (2,222) • Net operating cashflow of $2.6m before cash used in investing activities of $2.1
Slide 16: Strategy & Outlook
imexHs Strategy & Outlook
Slide 17: New Value Proposition
New Value Proposition Radiologists with Superpowers 1 Product. “The most advanced, contemporary and secure radiology AI enhanced software solution.” 2 Customer Service & Support. “Unparalleled customer support, setting a new industry standard.” Implementation, Training & 3 Updates. “The most efficie
Slide 18: Product and Software Updates
Product and Software Updates ● Universal Viewer v6.2 Enhancements ● Radiology Information System ➢ Hanging protocols customisation tool ➢ Achieved significant milestone - successfully feature, to improve radiologists’ experience. formulated a novel architecture, technology ➢ Integration and configur
Slide 19: Focus for FY24
Focus for FY24 Software Radiology Services 1) Rolling out New Value Proposition 1) Margin expansion ○ Enhanced digital security ○ Service levels 2) Focus and growth in Ideal Client ○ Integrated AI Profile ○ Unique tools for Radiologist ➢ Targeted towards Enterprise level Ideal Client 3) Tighten work
Slide 20: FY24 Outlook
FY24 Outlook Key drivers for revenue and earnings 2 guidance growth: • Revenue of $24.0 – $27.0m • Annualised Recurring Revenue (22% – 37% up vs FY23) recently contracted and contracted but not yet billing. • Underlying EBITDA of $1.5 - $3.5m (up vs $0.4m in • Current pipeline of opportunities. FY23
Slide 21: Q&A
Q&A
Slide 22: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 23: Disclaimer
Disclaimer Investors should be aware that certain financial measures included in this presentation are ‘non-IFRS financial information’ under ASIC Regulatory Guide 230: ‘Disclosing non-IFRS financial information’ published by ASIC and are not recognised under International Financial Reporting Standa
Slide 24: FY23 Results
FY23 Results 29 February 2024